Endocrinology, Vol 137, 555-560, Copyright © 1996 by Endocrine Society

ARTICLES

The role of the asparagine-linked oligosaccharides of the alpha-subunit in human thyrotropin bioactivity

FA Fares, N Gruener and Z Kraiem
Department of Biochemistry, Carmel Medical Center, Haifa, Israel.

TSH and the gonadotropins (FSH, LH, and hCG) are a family of heterodimeric proteins that share a common alpha-subunit and differ in their hormone-specific beta-subunit. The asparagine-linked (N-linked) oligosaccharides on these hormones are important in signal transduction. The N-linked oligosaccharides on the alpha-subunit have no effect on hCG and hFSH receptor binding, but are critical for their biological activity. Here, we analyzed the role of alpha-subunit N- linked oligosaccharides in human TSH (hTSH) bioactivity by site- directed mutagenesis and gene transfer. This was achieved by mutating the asparagine (Asn) residue in the N-linked glycosylation consensus sequence (Asn-X-Thr/Ser) to aspartic acid. The wild-type hTSH and its variants were expressed in Chinese hamster ovary cells. Wild-type alpha- subunit and its mutants (alpha 1, alpha 2, and alpha(1 + 2)) were efficiently combined with TSH beta-subunit and secreted as dimers. The bioactivity of TSH glycosylation variants was determined by measuring their abilities to stimulate cAMP formation and T3 secretion using a serum-free culture system of human thyroid follicles. Using this system, wild-type hTSH was significantly effective in the stimulation of cAMP formation and T3 secretion. Deletion of the oligosaccharide units from either site 1(alpha 1) or site 2(alpha 2) of the alpha- subunit increased the biological activity of the dimer by about 30%. However, deletion of carbohydrate units from both sites of hTSH alpha- subunit (alpha(1 + 2) resulted in a significant reduction in cAMP formation (by approximately 70%) and T3 secretion (by approximately 40%) compared to that with wild-type hTSH. These findings emphasize the importance of the alpha-subunit N-linked oligosaccharide chains on hTSH bioactivity.

This article has been cited by other articles:

				F. Fares, S. Ganem, T. Hajouj, and E. Agai Development of a Long-Acting Erythropoietin by Fusing the Carboxyl-Terminal Peptide of Human Chorionic Gonadotropin {beta}-Subunit to the Coding Sequence of Human Erythropoietin Endocrinology, October 1, 2007; 148(10): 5081 - 5087. [Abstract] [Full Text] [PDF]

				N. Azzam, R. Bar-Shalom, Z. Kraiem, and F. Fares Human Thyrotropin (TSH) Variants Designed by Site-Directed Mutagenesis Block TSH Activity in Vitro and in Vivo Endocrinology, June 1, 2005; 146(6): 2845 - 2850. [Abstract] [Full Text] [PDF]

				T. Zarinan, A. Olivares, D. Soderlund, J.P. Mendez, and A. Ulloa-Aguirre Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle Hum. Reprod., August 1, 2001; 16(8): 1611 - 1618. [Abstract] [Full Text] [PDF]

				J. A. Dias Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: II. A biochemical point of view Hum. Reprod., May 1, 2001; 16(5): 825 - 830. [Abstract] [Full Text] [PDF]

				F. A. Fares, S. Yamabe, D. Ben-Menahem, M. Pixley, A. J. W. Hsueh, and I. Boime Conversion of Thyrotropin Heterodimer to a Biologically Active Single-Chain Endocrinology, May 1, 1998; 139(5): 2459 - 2464. [Abstract] [Full Text] [PDF]

				M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family Endocr. Rev., August 1, 1997; 18(4): 476 - 501. [Abstract] [Full Text] [PDF]

				H. Leitolf, K. P. T. Tong, M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Bioengineering of Human Thyrotropin Superactive Analogs by Site-directed "Lysine-scanning" Mutagenesis. COOPERATIVE EFFECTS BETWEEN PERIPHERAL LOOPS J. Biol. Chem., August 25, 2000; 275(35): 27457 - 27465. [Abstract] [Full Text] [PDF]

				F. A. Fares, F. Levi, A. Z. Reznick, and Z. Kraiem Engineering a Potential Antagonist of Human Thyrotropin and Thyroid-stimulating Antibody J. Biol. Chem., February 9, 2001; 276(7): 4543 - 4548. [Abstract] [Full Text] [PDF]